Skip to content

MEDE GELAB

Active
Private limited companyfounded 2025active for 1 yearKrommestraat 18, 1970 Wezembeek-Oppem, BelgiumKBO/BCE: BE 1023.361.777
Summary

MEDE GELAB has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €68,117 and a net result of €65,117. Its solvency ranks better than 56% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€98,808total assets 2025
Equity
€68,117
Profit
€65,117
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 59 days early
Why 95raises riskFounded in 2025lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.89, cash €16,196Figures for financial year 2025 (filed 02-06-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 57% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 94
equity 68.9% of total assets
Liquidity 57
short-term debt 31.1% · cash 16.4%
Profitability 100
return on assets 65.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 06-2026: 0.3%highest value 07-2026: < 0.1%▼ -0.3 percentage points vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €6,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 2.89, above the usual 1.5; short-term debt: 31.1% and cash: 16.4% of total assets), and 31.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 57% on solvency, 34% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.89, cash €16,196
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 02-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
59 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: MENNIG, Joséphine Marie Thérèse…

Key points

  • Founded 17 months agofounded 15-05-2025 17 months View
  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €98,808 View

By topic

Financials

Financial year
2025
Total assets
€98,808
Profit
€65,117
Solvency
68.9%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
15-05-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
28
Annual meeting
Second Saturday of April at 12:00
Purpose
“De vennootschap heeft tot doel de uitoefening, in eigen naam en voor eigen rekening, van…” (deed in Dutch)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about MEDE GELAB

What is the company number of MEDE GELAB?
1023.361.777. In Belgium the VAT number is the company number with BE in front: BE 1023.361.777.
Where is MEDE GELAB based?
The registered office is at Krommestraat 18, 1970 Wezembeek-Oppem.Company details
What does MEDE GELAB do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDE GELAB?
Private limited company (BV).
When was MEDE GELAB founded?
On 15-05-2025.
Is MEDE GELAB still active?
Yes, MEDE GELAB is an active enterprise in the KBO register.
What is the turnover of MEDE GELAB?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is MEDE GELAB profitable?
In financial year 2025, MEDE GELAB made a profit of €65,117.
Where can I find the annual accounts of MEDE GELAB?
MEDE GELAB filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to MEDE GELAB

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.